Navigation Links
Pharmacyclics Identifies Functional Biomarkers for its Novel HDAC,Inhibitor and Demonstrates Preclinical Anti-Tumor Activity with,Bruton's Tyrosine Kinase Inhibitors

SUNNYVALE, Calif. and LOS ANGELES, April 18, 2007 /PRNewswire-FirstCall/ -- Pharmacyclics, Inc. today announced data from two preclinical studies, one identifying a functional biomarker for its novel histone deacetylase (HDAC) inhibitor and another demonstrating preclinical anti-tumor activity with its Bruton's tyrosine kinase (BTK) inhibitor compounds. The data were presented at the American Association for Cancer Research (AACR) 2007 Annual Meeting being held this week in Los Angeles.

Results of an in vitro study (Abstract #1966) demonstrate that Pharmacyclics' HDAC inhibitor, PCI-24781 inhibits homologous recombination, a cellular mechanism of DNA repair, by both down-regulating RAD51 gene expression, and by affecting the ability of the cell to form RAD51 foci at the site of the lesion. The RAD51 gene provides instructions for making a protein that is essential for the repair of damaged DNA. These data suggest that PCI- 24781 could be used successfully in combination with other cancer therapies that generate lesions repaired by homologous recombination, such as gamma- irradiation, cisplatin, and oxaliplatin, and show the usefulness of using RAD51, an enzyme, as a biomarker to predict clinical efficacy. Researchers observed that PCI-24781-treated cells are more sensitive to DNA damaging cancer agents, suggesting that it may act in part by inhibiting DNA repair. PCI-24781 is currently in Phase 1 clinical trials evaluating its safety and effectiveness in both solid and hematological malignancies.

"Not only have we further elucidated the mechanism by which our HDAC inhibitor may kill cancer cells, we have also identified a biomarker that may predict its efficacy in cancer patients," stated Richard A. Miller, M.D., president and CEO of Pharmacyclics. "We have filed patents based on this new information, and are moving this promising compound forward in clinical trials incorporating use of this bioma
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Pharmacyclics Announces Interim Results From Two Ongoing Phase 2 Trials Supporting Potential of Xcytrin Plus Chemotherapy to Treat Recurrent Non-Small Cell Lung Cancer
2. Pharmacyclics Announces Promising Results From Phase 2 Clinical Trial of Xcytrin in Recurrent, Metastatic Non-Small Cell Lung Cancer
3. Pharmacyclics Announces Presentations and Published Abstracts on Xcytrin at The 2007 American Society of Clinical Oncology Annual Meeting
4. Pharmacyclics Announces Presentations on Its Novel and Selective HDAC and Brutons Tyrosine Kinase Inhibitor Compounds
5. CV Therapeutics Identifies Potential Anti-Diabetic Mechanism of Action for Ranexa
6. Anacor Identifies a Novel Mechanism for Its Lead Anti-Fungal Drug, AN2690; Findings Published in Science
7. ARRIVE Registry Analysis Identifies Predictors of Stent Thrombosis in Real-World Use of Drug-Eluting Stents
8. NIDA Study Identifies Genes That Might Help Some People Abstain from Smoking
9. Rigel Ubiquitin Ligase Program Identifies Molecules With Anti-HIV Activity
10. Study in Cell by Magen BioSciences Co-Founder David E. Fisher Identifies New Roles in Skin Cancer Prevention for Key Tumor Suppressor Protein
11. BioLineRx Presents Data on BL-1040 at Cardiovascular Revascularization Therapies Conference Demonstrating Potential to Reduce Deterioration of Infarcted Heart Tissue and Maintain Functionality
Post Your Comments:
(Date:7/30/2014)... 30, 2014  Hologic, Inc. (NASDAQ: HOLX ... quarter ended June 28, 2014. Third Quarter ... 1.0% to $632.6 million, reflecting operational growth of 0.5% ... the same period in the prior year. , ... , Breast Health revenues grew 3.5%. , GYN ...
(Date:7/30/2014)... CryoLife, Inc. (NYSE: CRY), a leading medical device and ... announced today that its Board of Directors has approved ... of $0.03 per share of common stock outstanding.  The ... paid on September 19, 2014 to all common stockholders ... date for the quarterly dividend is September 10, 2014.  ...
(Date:7/30/2014)... YORK, Pa. , July 30, 2014 /PRNewswire/ ... UNIS ; ASX: UNS), a developer and supplier of ... of investments in manufacturing capacity, R&D, and facilities ... biotechnology companies for its products and services. During ... Company invested approximately $16 million in capital expenditures ...
Breaking Medicine Technology:Hologic Announces Third Quarter Fiscal 2014 Operating Results 2Hologic Announces Third Quarter Fiscal 2014 Operating Results 3Hologic Announces Third Quarter Fiscal 2014 Operating Results 4Hologic Announces Third Quarter Fiscal 2014 Operating Results 5Hologic Announces Third Quarter Fiscal 2014 Operating Results 6Hologic Announces Third Quarter Fiscal 2014 Operating Results 7Hologic Announces Third Quarter Fiscal 2014 Operating Results 8Hologic Announces Third Quarter Fiscal 2014 Operating Results 9Hologic Announces Third Quarter Fiscal 2014 Operating Results 10Hologic Announces Third Quarter Fiscal 2014 Operating Results 11Hologic Announces Third Quarter Fiscal 2014 Operating Results 12Hologic Announces Third Quarter Fiscal 2014 Operating Results 13Hologic Announces Third Quarter Fiscal 2014 Operating Results 14Hologic Announces Third Quarter Fiscal 2014 Operating Results 15Hologic Announces Third Quarter Fiscal 2014 Operating Results 16Hologic Announces Third Quarter Fiscal 2014 Operating Results 17CryoLife Announces Quarterly Cash Dividend for the Third Quarter 2014 2CryoLife Announces Quarterly Cash Dividend for the Third Quarter 2014 3Unilife Accelerates Investment to Meet Increasing Demand from New and Existing Customers 2Unilife Accelerates Investment to Meet Increasing Demand from New and Existing Customers 3Unilife Accelerates Investment to Meet Increasing Demand from New and Existing Customers 4Unilife Accelerates Investment to Meet Increasing Demand from New and Existing Customers 5
... SuccessEHS, a nationally recognized, certified practice management ... kicked off its annual Customer Conference at the Magic ... 2011. A record 361 attendees registered ... increase from last year,s figures. "Spotlight on Success" was ...
... Va., May 19, 2011 MinuteClinic, the retail health ... ), and Inova Health System, a leading Northern Virginia ... a year, have entered into a clinical affiliation that ... they provide in communities throughout Arlington, Fairfax, Fauquier, Loudoun ...
Cached Medicine Technology:SuccessEHS "Spotlight on Success" Customer Conference Begins 2MinuteClinic Forms Strategic Affiliation With Inova Health System in Northern Virginia 2MinuteClinic Forms Strategic Affiliation With Inova Health System in Northern Virginia 3MinuteClinic Forms Strategic Affiliation With Inova Health System in Northern Virginia 4
(Date:7/30/2014)... revitalized and expanded through a U.S.-funded effort that ... access and providing cutting-edge skills labs and other ... by participants of the $130 million Medical Education ... progress being made at the African institutions. Their ... by the journal Academic Medicine . Begun ...
(Date:7/30/2014)... Alan Mozes HealthDay Reporter ... who want to help their preschooler shed excess pounds may ... Youngsters whose parents joined them in a supervised behavioral ... enrolled in a traditional child-only program (an average difference of ... benefited, losing almost 15 pounds over two years, according to ...
(Date:7/30/2014)... July 30, 2014 The family of ... has filed a Xarelto lawsuit ( http://www.xareltolawsuitcenter.com/ ) ... Bernstein Liebhard LLP reports. According to the complaint, which ... of Vermont on July 25th, the decedent had been ... an irreversible brain bleed that ultimately led to his ...
(Date:7/30/2014)... 2014) The phrase "we caught it early" is possibly ... midst of a cancer diagnosis. Combating cancer in its ... certain part of the body, gives patients the best ... colon, prostate and other forms of cancer are touted ... providers recommend cancer screenings as a precautionary measure, especially ...
(Date:7/30/2014)... The Ehlers-Danlos National Foundation (EDNF) is pleased ... Chack will serve as chair. The board was voted ... Learning Conference in Houston, Texas July 10-12. , ... of us. From the rollout of the first EDNF ... Baltimore Medical Center to our September physicians conference to ...
Breaking Medicine News(10 mins):Health News:Journal supplement details progress in African medical education 2Health News:Journal supplement details progress in African medical education 3Health News:Make Kids' Weight Loss a Family Affair, Study Suggests 2Health News:Make Kids' Weight Loss a Family Affair, Study Suggests 3Health News:Make Kids' Weight Loss a Family Affair, Study Suggests 4Health News:Xarelto Lawsuit Alleges Man’s Death from Uncontrollable Brain Bleeding Was Caused by Xarelto, Bernstein Liebhard LLP Reports 2Health News:Xarelto Lawsuit Alleges Man’s Death from Uncontrollable Brain Bleeding Was Caused by Xarelto, Bernstein Liebhard LLP Reports 3Health News:UK psychologist creates patient tool to assist with lung cancer screening decision 2Health News:UK psychologist creates patient tool to assist with lung cancer screening decision 3Health News:Ehlers-Danlos National Foundation Announces New Leadership 2
... in China is smaller than that of many other countries, ... diabetics// of age between 20 and 79 in 2003. ... in China, while diabetics are mostly aged between 60 to ... Department in Beijing University People's Hospital. ,"Although no ...
... the Mecca of Fashion, Paris, have uncovered a mechanism ... natural chemical called opiorphin//, a natural pain alleviator, far ... their experiments, rodents were found to experience pain relief ... with the usual dosage of morphine. The finding which ...
... with incriminating evidence that warns non-vegetarians who binge on red ... out that eating more than one and a half servings ... breast cancer and another study that vitamin supplements seem ... diseases except for vitamin C which seems to show some ...
... fatty acid known as docosahexaenoic acid (DHA) in their ... dementia and Alzheimer’s disease, according to a study. ... been found to increase the risk of dementia and ... of cases of dementia in the elderly, according to ...
... Shelnutt and Yujiang Song from Sandia National Laboratories have ... attaches //to a cell which involves a new process that ... Security Administration laboratory. ,An upcoming issue of the German ... Angewandte Chemie Int. Ed which has currently published the same ...
... be just a matter of eating a salad a day. ... Americans will welcome a new study that could keep them ... study, conducted by the UCLA School of Public Health and ... revealed eating salads with salad dressing and raw vegetables is ...
Cached Medicine News:Health News:Red alert to women against red meat consumption 2Health News:Higher Level of Certain Fatty Acid Associated with Lower Dementia Risk 2Health News:Novel methods to view how a drug attaches to a cell 2Health News:A Salad a Day Keeps the Doctor Away This Winter 2
... metal frames ensure cleanroom ... cleanliness and chemical resistance. ... with user-friendly pnuematic controls ... Fixed footring standard. Five ...
... The ideal modular cleanroom for ... applications that require cleanliness (to Class ... are precision-joined to create ultra-smooth surfaces ... and disinfect. One-inch radius corners simplify ...
... modular cleanroom for biological safety labs ... cleanliness (to Class 10/ISO 3) and ... create ultra-smooth surfaces that are easy ... radius corners simplify cleaning. Unique double-wall ...
Inquire...
Medicine Products: